Biologics in Joint Preservation: What Works and What's Still Experimental

Biologics in Joint Preservation: What Works and What's Still Experimental

•15 min read•Sports Injuries, Arthritis, Joint Pain
Written by Dr. Karthik DMedically reviewed by Dr. Naveen Kumar L.V on 9 November 2026Updated 15 October 2025

Biologics – treatments that use blood, cells or tissue to help joints heal – have a real but specific role in joint preservation: some are well supported, such as cultured cartilage cell implants for focal defects and cell therapy for early hip avascular necrosis, while popular injections like PRP and “stem cells” for knee arthritis have mixed or disappointing results in the best trials. This guide separates the evidence from the hype.

Joint preservation aims to keep your own joint working for as long as possible and delay or avoid joint replacement. Biologics are one set of tools for this, alongside physiotherapy, weight management, alignment correction and surgical repair. Here, the team at Sports Orthopedics Institute explains each option, what the research shows, and who is most likely to benefit.

Key takeaways

  • Biologics work best on focal, early problems – a cartilage defect, a tendon repair, early avascular necrosis – not on widespread, advanced arthritis.
  • Cultured cartilage cell implantation (ACI/MACI) has randomised-trial evidence for larger cartilage defects in younger patients.
  • PRP for knee arthritis outperforms hyaluronic acid in many meta-analyses, but a large placebo-controlled trial found no benefit over saline.
  • Stem cell injections for knee arthritis were no better than a steroid injection in a large 2023 trial, and in India they are permitted only within approved clinical trials.
  • Alignment, load and rehabilitation matter as much as the biologic itself.

How to read the evidence ratings

Rating

What it means

Strong

Consistent randomised controlled trials or high-quality meta-analyses

Moderate

Multiple comparative studies or smaller RCTs with consistent findings

Limited / mixed

Small or conflicting studies; benefit possible but uncertain

Experimental

Laboratory, animal or early human studies only

What Are Biologics?

“Biologics” is an umbrella term for treatments derived from living material that aim to reduce inflammation or support tissue healing. They range from a simple injection prepared from your own blood to cartilage cells grown in a laboratory.

Type

What it is

How it is given

Platelet-rich plasma (PRP)

Your own blood, spun to concentrate platelets and their growth factors

Injection, or applied during surgery

Bone marrow aspirate concentrate (BMAC)

Bone marrow from your hip, concentrated to enrich cells and growth factors

Injection, or during surgery

Adipose-derived cells (SVF)

Cells extracted from your own fat by mini-liposuction

Injection

Cultured chondrocytes (ACI / MACI)

Your own cartilage cells, grown in a lab for 3–4 weeks and reimplanted

Surgery (two stages)

Bone marrow stimulation (microfracture)

Small holes in the bone under a cartilage defect release marrow cells

Arthroscopic surgery

Autologous conditioned serum (IL-1Ra)

Blood processed to raise anti-inflammatory proteins

Injection

Scaffolds and growth factors

Collagen or synthetic matrices, sometimes with added growth factors

Surgery

Note that most injected “stem cell” products contain only a small fraction of true stem cells; their effects are thought to come mainly from signalling molecules rather than cells turning into new cartilage.

Platelet-Rich Plasma (PRP)

PRP is the most widely used biologic, and also one of the most debated: results depend heavily on the condition, the PRP preparation and what it is compared with.

PRP for knee osteoarthritis – Rating: Limited / mixed

  • Compared with hyaluronic acid: many meta-analyses of randomised trials find PRP gives better pain relief at 6–12 months. One analysis of 20 RCTs reported PRP reduced pain more effectively than hyaluronic acid at both time points (Journal of Orthopaedic Surgery and Research, 2020).
  • Compared with placebo: the RESTORE trial (JAMA, 2021) randomised 288 adults with mild-to-moderate knee osteoarthritis to three PRP or three saline injections. At 12 months there was no significant difference in pain or cartilage loss, and the authors concluded the findings do not support PRP for knee osteoarthritis (PubMed).

What this means for you: PRP may help some people with early knee arthritis, particularly where other injections have not, but expectations should be modest. It does not regrow cartilage and should accompany, not replace, strengthening and weight management.

PRP for tendon problems – Rating: Limited to moderate

PRP is commonly used for chronic tennis elbow and other tendinopathies that have not responded to rehabilitation. Results vary between studies; exercise-based rehab remains first-line, and PRP is an option for persistent cases.

PRP during surgery

See the section on surgical augmentation below – for example, PRP added to rotator cuff repair.

Cell-Based Injections (“Stem Cell Therapy”)

Injected cell therapies for knee arthritis have not lived up to their marketing: in the largest trial to date, none performed better than a standard steroid injection.

What the evidence shows – Rating: Limited

A 2023 multicentre randomised trial published in Nature Medicine compared bone marrow concentrate, fat-derived cells (SVF) and umbilical cord-derived cells with a corticosteroid injection in 480 patients with knee osteoarthritis. At one year, none of the three cell injections was superior to another or to the steroid, and none changed MRI arthritis scores (Nature Medicine). No serious procedure-related adverse events occurred.

The theory that injected cells turn into new cartilage has not been demonstrated in patients. Any benefit appears to come from anti-inflammatory signalling, similar to other injections.

The regulatory position in India

Under the ICMR–DBT National Guidelines for Stem Cell Research, stem cell use other than approved blood-forming stem cell transplants is investigational and should only take place within an approved, monitored clinical trial (Nature India). If a clinic offers stem cell injections for joint arthritis as routine paid treatment, ask whether it is part of a registered clinical trial.

An exception with better evidence: bone marrow cells used during core decompression for early hip avascular necrosis (see below).

Cartilage Restoration for Focal Defects

For a well-defined cartilage defect in an otherwise healthy joint, biological restoration has the strongest evidence of any biologic approach. These procedures are for focal lesions, not for widespread arthritis.

Procedure

What happens

Best for

Evidence

Microfracture

Small holes in the bone release marrow cells that form fibrocartilage

Small defects (under about 2 cm²), lower-demand patients

Moderate; results often decline after 3–5 years

Osteochondral autograft (OATS / mosaicplasty)

Plugs of healthy cartilage and bone moved from a low-load area

Small to medium defects, including with bone loss

Moderate

Autologous chondrocyte implantation (ACI / MACI)

Your cartilage cells are harvested, grown for 3–4 weeks, then implanted (on a membrane or in a gel)

Larger defects (around 2–3 cm² or more) in younger, active patients

Strong for larger defects

Key trial: MACI vs microfracture

The SUMMIT randomised trial (144 patients) found that for knee cartilage defects of 3 cm² or larger, MACI gave clinically and statistically better pain and function than microfracture, and the advantage was maintained at five years (American Journal of Sports Medicine).

Availability in India

Autologous chondrocyte implantation is available in India through CDSCO-approved cultured cartilage cell products. An Indian multicentre study of a gel-based ACI product (CARTIGROW) in patients aged 19–38 reported sustained improvement in pain and function at four years, though it was a small study of 14 patients (International Orthopaedics, 2022).

Important: cartilage restoration fails if the knee is malaligned or unstable. Correcting alignment (osteotomy) or ligament instability is often part of the plan.

Biologics as an Add-On to Surgery

Adding a biologic to a surgical repair is one of the more promising uses, because the repair provides the structure and the biologic may improve healing.

Rotator cuff repair – Rating: Moderate

Re-tears after rotator cuff repair are common, especially with large tears. A meta-analysis of 17 studies found a lower re-tear rate with PRP augmentation (19.3% vs 25.4%), with leukocyte-poor PRP performing best (PubMed). Another meta-analysis found PRP reduced re-tears but did not improve clinical scores (Feltri et al., 2022). Collagen patches and other scaffolds are also used to reinforce repairs, with emerging evidence.

Meniscus repair – Rating: Limited

Some meta-analyses report fewer repair failures with PRP; others find no difference. It may be considered, particularly for tears with poorer blood supply. Combining meniscus repair with ACL reconstruction, or making small holes in nearby bone (marrow venting), also adds healing factors to the joint.

ACL reconstruction – Rating: Limited

PRP and other biologics have been studied to speed graft healing, but there is no convincing evidence that they improve clinical outcomes or reduce re-injury. They are not routinely needed.

Hip Avascular Necrosis: Core Decompression with Cell Therapy

For early avascular necrosis (AVN) of the hip – before the ball of the joint has collapsed – adding bone marrow cells to core decompression is one of the better-supported uses of cell therapy.

In AVN, part of the femoral head loses its blood supply and can collapse, leading to arthritis. Core decompression drills a channel into the affected bone to relieve pressure; bone marrow concentrate can then be placed into the channel.

Evidence – Rating: Moderate. A meta-analysis of seven studies found that adding cell therapy reduced the odds of femoral head collapse about five-fold compared with core decompression alone (Acta Orthopaedica). A later meta-analysis of 20 studies found cell therapy also reduced conversion to hip replacement, particularly in pre-collapse stages (Bone & Joint Research, 2021). Many of the underlying studies are small, but the direction of evidence is consistent.

Timing is everything: once the femoral head has collapsed, hip preservation becomes much less successful. Anyone with hip pain and AVN risk factors – long-term steroid use, heavy alcohol use, sickle cell disease or previous hip injury – should get an early MRI.

Other and Emerging Biologics

  • Autologous conditioned serum (IL-1Ra): blood processed to concentrate an anti-inflammatory protein, injected for arthritis. Rating: Limited.
  • Bone morphogenetic proteins (BMPs): powerful bone-forming proteins used in selected spinal fusion and complex fracture cases; they have no role in routine joint arthritis. Rating: specialist use only.
  • Exosomes: cell-derived vesicles promoted by some clinics. There are no approved exosome products, and human evidence in orthopaedics is minimal. Rating: Experimental.
  • Gene therapy, 3D-bioprinted scaffolds, nanomaterials and AI-guided treatment selection: active research areas, not yet clinical treatments. Rating: Experimental.

Be cautious of any clinic promising that an injection will “regrow” cartilage in an arthritic joint – no current injection has been shown to do this.

Joint-by-Joint Summary

Joint

Where biologics have the best evidence

Where evidence is weak or mixed

Knee

ACI/MACI for larger focal cartilage defects; osteochondral grafts; cartilage repair with alignment correction

PRP and cell injections for arthritis; PRP in ACL reconstruction

Hip

Core decompression with bone marrow cells for pre-collapse avascular necrosis

Injections for hip arthritis

Shoulder

PRP augmentation to reduce rotator cuff re-tears

Injections for shoulder arthritis; labral repair augmentation

Ankle

Cartilage restoration for osteochondral lesions of the talus

Injections for ankle arthritis

Elbow and tendons

PRP for selected chronic tendinopathies after failed rehab

Routine first-line use

Who Benefits – and When Joint Replacement Is Better

The best candidates are younger, active people with a focal, early problem in a well-aligned, stable joint.

Good candidates

  • Focal cartilage defects, typically in people under about 50
  • Early (pre-collapse) hip avascular necrosis
  • Tendon or rotator cuff problems where a repair needs extra support
  • Early arthritis, where expectations are modest and other measures have been tried

Alignment and load come first

A biologic cannot survive in a joint that is overloaded. Bow legs or knock knees, ligament instability or excess body weight concentrate force on damaged cartilage. Correcting these – with an osteotomy (realigning the bone), ligament reconstruction or weight loss – is often essential for joint preservation to succeed.

When joint replacement is the better option

For advanced, “bone-on-bone” arthritis with deformity and significant daily pain, joint replacement gives far more predictable relief. Biologics should not be used to delay a replacement that would clearly help you. A staged approach – trying preservation first when disease is borderline – is reasonable, because most biologic procedures do not prevent later replacement.

Factors that reduce success

Smoking, uncontrolled diabetes, obesity, inflammatory arthritis, older age, advanced disease, and poor adherence to rehabilitation.

Recovery and Rehabilitation

Recovery depends on the procedure: an injection means days of modified activity, while cartilage restoration needs months of protected rehab while new tissue matures.

Procedure

Early phase

Return to full activity

PRP or other injection

2–3 days of relative rest; a temporary flare of pain is common

Usually within 1–2 weeks; any benefit builds over 6–12 weeks

Rotator cuff repair with augmentation

Sling for about 4–6 weeks; guided passive movement

4–6 months; longer for heavy overhead work

Microfracture or ACI/MACI

Protected weight-bearing and early motion for about 6 weeks

Running often from 6–9 months; pivoting sport around 12 months

Core decompression for hip AVN

Crutches with limited weight-bearing for about 6 weeks

Gradual return over 3–4 months

Tips for the best result:

  • Follow weight-bearing and motion restrictions closely – regenerating tissue is vulnerable early on.
  • Ask your doctor before taking anti-inflammatory painkillers around a PRP injection, as some clinicians advise avoiding them for a short period.
  • Commit to a structured strengthening programme; muscle strength protects the joint.
  • Expect gradual improvement: cartilage repair tissue keeps maturing for 12–24 months.

Cost, Insurance and Questions to Ask

Costs vary widely, and many injection-based biologics are not covered by insurance. PRP usually costs less per session but may be repeated; cultured cell procedures such as ACI are considerably more expensive because of laboratory processing. Surgical procedures with biologic augmentation are more often covered when the underlying surgery is medically necessary. You will receive an itemised estimate after assessment.

Questions to ask before any biologic treatment

  1. What exactly is being injected or implanted, and how is it prepared?
  2. What is the evidence for this treatment in my specific condition?
  3. What results should I realistically expect, and by when?
  4. How many sessions might I need, and what is the total cost?
  5. If this is a stem cell product, is it part of an approved, registered clinical trial?
  6. Does my alignment, stability or weight need to be addressed first?
  7. What is the plan if this does not work?

How Sports Orthopedics Institute Can Help

We use biologics where the evidence supports them – and tell you plainly when it doesn't.

  • Accurate diagnosis: examination, standing X-rays and MRI to define the problem and the joint's alignment.
  • The full joint-preservation toolkit: cartilage restoration, osteotomy, ligament and meniscus repair, rotator cuff repair with augmentation, and core decompression for early AVN.
  • Honest, evidence-based advice: clear information on the expected benefit, cost and alternatives, including when joint replacement is the better choice.
  • Structured rehabilitation: programmes matched to the biology of healing.

Want to keep your own joint working for longer? Book a consultation with our joint preservation team in Bengaluru.

Frequently Asked Questions

What does “biologics in joint preservation” mean?

It means using treatments made from blood, cells or tissue – such as PRP, bone marrow concentrate or cultured cartilage cells – to help a damaged joint heal or function better, with the aim of keeping your own joint and delaying or avoiding replacement.

Can biologics regrow cartilage in an arthritic knee?

No injection has been shown to regrow cartilage in an arthritic joint. Surgical cartilage restoration such as ACI or MACI can repair a focal defect in an otherwise healthy joint, which is a different situation from widespread arthritis.

Does PRP work for knee arthritis?

The evidence is mixed. PRP often outperforms hyaluronic acid in trials, but a large placebo-controlled trial found no benefit over saline at 12 months. Some patients report relief, but expectations should be modest.

Are stem cell injections effective for joint arthritis?

In a large 2023 trial, bone marrow, fat-derived and umbilical cord cell injections were no better than a steroid injection at one year. In India, stem cell use for arthritis should only take place within an approved clinical trial.

Which biologic treatments have the strongest evidence?

Cultured cartilage cell implantation (ACI/MACI) for larger focal cartilage defects, and bone marrow cells added to core decompression for early hip avascular necrosis. PRP added to rotator cuff repair also has supportive evidence for reducing re-tears.

Who is a good candidate?

Usually younger, active people with a focal, early problem in a well-aligned, stable joint. People with advanced, bone-on-bone arthritis generally do better with joint replacement.

How long do the benefits last?

It depends on the treatment. Benefits from injections, when they occur, typically last months. Successful cartilage restoration can last many years: MACI results were maintained at five years in a randomised trial.

Can biologic treatment prevent joint replacement?

In the right situation – such as a repaired cartilage defect or early hip AVN treated before collapse – it can delay or sometimes avoid replacement. It cannot reverse advanced arthritis.

Are biologic treatments safe?

Treatments made from your own blood or tissue have a low risk of serious side effects. Temporary pain and swelling are common after injections. Risks rise with surgical procedures and with unregulated products from unverified sources.

Are biologics covered by insurance in India?

Injection-based biologics are often not covered. Surgical procedures that include a biologic are more likely to be covered when the surgery itself is medically necessary. Check with your insurer before treatment.

References

Disclaimer: This article is for educational purposes only and does not replace a consultation with a qualified orthopedic specialist.

Related articles